Clinical Trials Browser

Completed × Adenocarcinoma × Leucovorin × Clear all

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT04299880 2023-11-08

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pancreatic Neoplasms

Clinical Trials

ARION

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

FOLFOX-D

MEGA

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

FABLOx

FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

CatuNeo

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

HerFLOT

Phase I FOLFOX Combination

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination